Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Catholic hospital sued for refusing to perform emergency abortion on a hemorrhaging patient
California Attorney General Rob Bonta is suing Providence St. Joseph Hospital to discourage an incident like this from happening in the future.
Newsom vetoes bill to regulate private equity transactions in healthcare
Assembly Bill 3129 would have given the California Attorney General oversight of all private equity investments or purchases involving a healthcare entity. Gov. Gavin Newsom argued that a similar regulatory framework is already in place.
FDA announces recall of Pfizer's fast-tracked sickle cell drug
The drugmaker is voluntarily withdrawing Oxbryta from the market due to a higher-than-acceptable risk of death.
Public health coalition wins lawsuit against EPA for lack of fluoride oversight
A federal judge in California ruled existing evidence of the negative effects of fluoride in drinking water warrants an investigation and potential action from the Environmental Protection Agency.
Cardiology groups cheer new bill that would improve access to Medicare claims data
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.

Maryland all-payer model expands beyond hospitals

CMS has approved an extension of Maryland’s model of offering a fixed payment for most hospital services, allowing physician practices and nursing homes to voluntarily participate in a program that has saved Medicare hundreds of millions of dollars.

May 15, 2018

CMS rejects Iowa’s plan to direct more Medicaid funds to private nursing homes

Iowa’s “supplemental payment plan” for nursing homes was rejected by CMS over concerns about having county hospitals assume the licenses of for-profit nursing homes.

May 14, 2018

MRI prices higher in the US

A data report released by the Kaiser Family Foundation and the Peterson Center on Healthcare showed the U.S. has higher prices for many healthcare services compared to other high-income countries, including on MRIs and joint replacements, and how some prices have risen faster than inflation.

May 14, 2018

5 things to know about Trump’s plan to lower drug prices

As a candidate, President Donald Trump had criticized pharma companies for “getting away with murder.” In remarks on Friday, May 11, he did bash the industry’s lobbying power while also lumping in insurance companies, distributors and pharmacy benefit managers (PBMs) as part of the “broken system” that has sent drug prices soaring.

May 11, 2018

Health spending, prices growing even as insurance coverage falls

Year-over-year price growth was 2.2 percent in April 2018, which Altarum said was fractionally above the March rate, setting a six-year high for price growth in the sector. Hospital price growth fell slightly to 3.7 percent.

May 11, 2018

3 things to know about ‘healthcare voters’ in 2018 elections

Four states held primary elections on May 8, kicking off a busy election season that will see most Tuesdays from now until mid-September having one or more states’ voters casting ballots. Judging by the latest poll from the Kaiser Family Foundation, healthcare will be a major issue for many in the coming months.

May 10, 2018

Trump’s pharma plan: Raise prices overseas to lower them in US

President Donald Trump is set to deliver a speech on pharmaceutical prices on May 11—but rather than matching his campaign rhetoric saying drug industry is “getting away with murder,” he’s expected to be cheered by pharma companies for calling for foreign countries to pay more for drugs, rather than bring down prices in the U.S.

May 10, 2018

Hospitals without competition have higher prices

When hospitals enjoy a monopoly in their market, their prices for privately insured patients are 12.5 percent higher on average, according to a study encompassing 88 million people covered by Aetna, Humana and UnitedHealthcare. The differences disappeared when consolidating facilities were located more than 25 miles apart.

May 9, 2018

Around the web

Cardiovascular Business

Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.

Cardiovascular Business

Watchdog group, fearful of fraud, wants more oversight for remote patient monitoring

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Cardiovascular Business

Most recalled cardiovascular devices gained FDA approval with little to no clinical evidence

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing.